tradmap

BIO Bio-Rad Laboratories, Inc.

$282.40 -0.80%

Healthcare · Laboratory Analytical Instruments

Bio-Rad Laboratories, Inc. (BIO) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $7.6 billion. Shares last traded at $282.40, 17.7% below their 52-week high. Over the past year the stock is up 22.5%. BIO trades at a price-to-earnings ratio of 10.02, below the Laboratory Analytical Instruments median of 28.17. Net profit margin is 29.4%, above the peer median of -1.5%. Revenue grew 0.7% year over year.

Market Cap
$7.6B
Shares Out
27.0M
EPS (TTM)
$-1.96
P/E Ratio
10.02
P/S Ratio
2.95
P/B Ratio
1.11
Dividend / Share
Dividend Yield
52-Week High
$342.95
52-Week Low
$228.40
Volume
24,710
Avg Vol (3m)
23,435.016

Performance

1W
-3.44%
1M
+0.37%
3M
+6.60%
6M
-6.46%
YTD
-7.52%
1Y
+22.52%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
45.50
SMA (50)
$283.49
SMA (200)
$293.73
Price vs SMA50
-0.38%
Price vs SMA200
-3.86%
ATR (14)
$8.77

Financials

Revenue
$2.6B
Net Income
$760M
Gross Margin
51.9%
Operating Margin
1.8%
Net Margin
29.4%
Return on Equity
11.1%
Return on Assets
7.8%
Current Ratio
3.21
Debt / Equity
0.18
Revenue Growth (YoY)
+0.7%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $-19.55 2026-04-30
FY 2025 $27.85 2026-02-13
Q3 2025 $1.46 2025-10-29
Q2 2025 $13.84 2025-07-31
Q1 2026 $2.29 2026-04-30
FY 2025 $-65.36 2026-02-13

Full earnings history →

Laboratory Analytical Instruments peers

BIO vs 14 industry peers (Laboratory Analytical Instruments), by market cap.

P/E vs peers
10.02 / 28.17 med
-64% discount
P/S vs peers
2.95 / 2.95 med
+0% premium
Net margin vs peers
29.4% / -1.5% med
above median
1–14 of 14
AAgilent Technologies$35.9B27.555.1718.8%+2.23%
WATWaters Corporation$34.9B54.3211.0320.3%-0.44%
ILMNIllumina, Inc.$24.5B28.805.6419.6%+1.68%
MTDMettler Toledo$23.1B26.595.7421.6%+1.22%
RVTYRevvity$11.1B46.223.908.4%+2.23%
BRKRBruker Corp$8.7B-1049.062.53-0.2%+4.51%
BIOBio-Rad Laboratories, Inc.$7.6B10.022.9529.4%-0.80%
AVTRAvantor, Inc.$6.5B-12.321.00-8.1%+1.16%
TXG10x Genomics, Inc.$4.5B-102.516.94-6.8%+8.24%
ALMRAlamar Biosciences, Inc.$1.5B+8.56%
EYPTEyepoint, Inc.$1.1B-4.91+3.35%
CTKBCytek Biosciences, Inc.$488M-7.342.42-33.0%-4.91%
PACBPacific Biosciences Of California, Inc.$432M-0.79+3.35%
LABSTANDARD BIOTOOLS INC.$324M-4.323.79-87.8%+2.65%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.